Dramex Interior Finish (Bondex)

Product Description

Dramex Interior Finish was a pre-mixed interior finishing compound manufactured by Bondex, a company that produced a range of construction and maintenance products throughout the mid-twentieth century. Sold under the Bondex brand, Dramex was marketed as a ready-to-use product designed to smooth and finish interior wall and ceiling surfaces, functioning within the broader category of joint compounds and surface finishing materials that were widely adopted by the construction industry during the postwar building boom.

The product was manufactured and distributed from approximately 1948 through 1977, a period that coincided with peak demand for residential and commercial construction across the United States. During these decades, pre-mixed finishing compounds represented a significant advancement over traditional plaster systems, offering faster application times and compatibility with the expanding use of gypsum wallboard systems. Bondex positioned Dramex as a versatile interior finish suitable for a range of applications, from new construction to repair and renovation work.

As with many building products of this era, Dramex Interior Finish was formulated to take advantage of the physical properties that made asbestos an attractive additive — specifically its ability to improve workability, bind materials together, resist cracking, and provide a smooth, durable finish surface. The product remained on the market through the mid-1970s, when regulatory attention to asbestos in consumer and commercial building products intensified and manufacturers began reformulating or discontinuing asbestos-containing product lines.

Asbestos Content

Litigation records document that Dramex Interior Finish contained chrysotile asbestos as a component of its formulation. Chrysotile, also known as white asbestos, is the most commercially prevalent form of asbestos and was extensively used in building materials throughout the twentieth century. It belongs to the serpentine mineral group and is characterized by long, curly fibers that were valued in manufacturing for their flexibility, tensile strength, and resistance to heat and chemical degradation.

Plaintiffs alleged that chrysotile asbestos was incorporated into Dramex as a functional ingredient, consistent with common industry practice for joint compounds and finishing products of the era. In such formulations, asbestos fibers served to improve the product’s adhesion, reduce shrinkage during drying, and enhance the overall texture and durability of the finished surface. These properties made chrysotile a standard additive across competing brands and product lines until regulatory and public health pressures led to its elimination.

Although chrysotile was long considered by some industry representatives to be less hazardous than amphibole asbestos varieties such as crocidolite or amosite, the scientific and regulatory consensus — as reflected in OSHA standards, EPA rulemaking under AHERA, and extensive occupational health research — affirms that chrysotile exposure presents serious risks of asbestos-related disease, including mesothelioma, asbestosis, and lung cancer. No safe level of occupational asbestos exposure has been established by regulatory authorities.

How Workers Were Exposed

Industrial workers and tradespeople who handled Dramex Interior Finish during its years of production were potentially exposed to airborne asbestos fibers through the normal use of the product. Litigation records document that plaintiffs identified exposure occurring during the mixing, application, sanding, and cleanup phases associated with interior finishing work.

Although Dramex was marketed as a pre-mixed product, finishing compounds of this type routinely required additional mixing or thinning on the job site, activities that could disturb dry or partially dried asbestos-containing material and release fibers into the breathing zone of workers. Application by trowel, knife, or mechanical spreader could similarly generate fiber release depending on product consistency and application method.

The most significant exposure potential, as documented in occupational health research and reflected in litigation records, arose during the sanding and abrading of dried joint compound and finishing material. When a dried asbestos-containing finish was sanded to achieve a smooth surface — a standard and necessary step in the finishing process — the mechanical action broke asbestos fibers into respirable-sized particles that remained suspended in workplace air for extended periods. Workers performing this task, as well as bystanders in the immediate area, could inhale fibers without visible dust serving as an adequate warning.

Plaintiffs alleged that workers using Dramex Interior Finish were not adequately warned of the hazards associated with asbestos inhalation during the decades in which the product was sold. Litigation records further document that industrial workers involved in construction, renovation, and building maintenance who used Bondex products including Dramex as part of their regular job duties identified the product as a source of occupational asbestos exposure. Renovation and demolition scenarios presented additional exposure risk, as previously applied finishes were disturbed, cut, or removed — activities capable of releasing fibers from material that had been in place for years or decades.

OSHA’s current permissible exposure limit for asbestos is 0.1 fibers per cubic centimeter of air as an eight-hour time-weighted average, with an excursion limit of 1.0 f/cc for any thirty-minute period. These standards reflect the agency’s determination that asbestos exposure in occupational settings poses documented health risks requiring regulatory control.

Documented Product Identification

The following details are drawn from public asbestos litigation records, manufacturer catalog pages, technical manuals, and corporate history materials. Each item reflects the product as documented in those sources.

Documented asbestos-use period: 1961-1981

Corporate context: Also known as Reardon, RPM, and Republic Powdered Metals. Warning labels were added to packaging in 1972 or 1973.

Brand identification: Products sold under multiple brand names including Bondex, Reardon’s, Trax, Montgomery Ward, Penncraft, Hi & Dri, NPD, Cook’s Lifeline, Brod Dirgan, F.O. Pierce, and Metro

Documented asbestos components: chrysotile.

Industries served: residential construction, commercial construction, mobile home manufacturing, drywall installation.

Documented product lines:

  • Dramex Interior Finish (1961-1977). Interior texture paint containing 7.3% chrysotile asbestos. — asbestos components: chrysotile.
  • Dramax Exterior Finish (1961-1977). Exterior paint containing 7.2% chrysotile asbestos. — asbestos components: chrysotile.
  • Water Putty (1961-1977). Interior patching compound containing 6.5% chrysotile asbestos. — asbestos components: chrysotile.
  • Handy Patch All Purpose Patcher (1961-1977). Interior patching compound containing 7.5% chrysotile asbestos. — asbestos components: chrysotile.
  • SX Joint Cement (1961-1977). Drywall joint treatment material containing 14.8% chrysotile asbestos. — asbestos components: chrysotile.
  • All Purpose Joint Cement (1961-1977). Drywall joint treatment material containing 5% chrysotile asbestos. — asbestos components: chrysotile.
  • Ready-Mixed Joint Cement (1961-1977). Drywall joint treatment material containing 3.8% chrysotile asbestos. — asbestos components: chrysotile.
  • Block Filler & Primer (1961-1977). Cite block filler and primer containing 9.1% chrysotile asbestos. — asbestos components: chrysotile.

All Bondex asbestos-containing products used chrysotile asbestos. Products were sold under numerous private label and store brand names through retailers including Montgomery Ward. Sanding of dried joint compounds was a documented application method.